Yevgeniy Y. Studentsov

Enhanced Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Virus-Like Particles of Human Papillomavirus

Howard D. Strickler, John Schiller, Rolando Herrero, 2002, Journal of Clinical Microbiology.

A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.

R. Ziegler, S. Weinstein, L. Brinton, 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Development of a non-denaturing electrophoresis system for characterization of neutralizing epitopes on HPV virus-like particles.

R. Burk, Yevgeniy Y. Studentsov, 2007, Journal of virological methods.

Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia.

M. Einstein, R. Burk, L. Reimers, 2010, Gynecologic oncology.

Natural History of Human Papillomavirus Type 16 Virus-Like Particle Antibodies in Young Women

R. Burk, R. Bierman, Yevgeniy Y. Studentsov, 2004, Cancer Epidemiology Biomarkers & Prevention.

Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles.

R. Burk, R. Bierman, L. Beardsley, 2002, The Journal of infectious diseases.

Anti-HPV16 Antibody Titers Prior to an Incident Cervical HPV16/31 Infection

V. Shankar, R. Burk, N. Schlecht, 2021, Viruses.

Progesterone and 17β-Estradiol Enhance Regulatory Responses to Human Papillomavirus Type 16 Virus-Like Particles in Peripheral Blood Mononuclear Cells from Healthy Women

S. Klein, R. Burk, H. Farzadegan, 2010, Clinical and Vaccine Immunology.

Polymer-Based Enzyme-Linked Immunosorbent Assay Using Human Papillomavirus Type 16 (HPV16) Virus-Like Particles Detects HPV16 Clade-Specific Serologic Responses

R. Burk, M. Marks, R. Bierman, 2003, Journal of Clinical Microbiology.